Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F8Q6N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,738
Award facts
- Contract value 100% obligated
- $12,737.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,737.58 delivery order to Amerisourcebergen Drug Corp on June 8, 2026, for RINVOQ ER 15 mg tablets (30-count unit of use), firm fixed-price, with ultimate completion on June 9, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen is a subsidiary of Cencora, Inc., a pharmaceutical distributor and medical supplier serving the Department of Defense and federal healthcare systems as a prime contractor on full-and-open competitive awards.
Quick answers
Who was awarded contract SPE2DR26F8Q6N?
SPE2DR26F8Q6N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 8, 2026.
How much is contract SPE2DR26F8Q6N worth?
The government has obligated $12,738 on SPE2DR26F8Q6N.
Is contract SPE2DR26F8Q6N an order under another contract?
Yes. SPE2DR26F8Q6N is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8Q6N competed?
The extent of competition for SPE2DR26F8Q6N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award